ZOLL Medical Corporation has acquired several ventilator product lines from Vyaire Medical to enhance its respiratory care portfolio and better serve a broader range of clinicians and patients.
Information on the Target
ZOLL Medical Corporation has successfully acquired several ventilator product lines from Vyaire Medical, which include the bellavista®, LTV®, 3100 HFOV, and fabian® products. This strategic move aims to bolster ZOLL's capacity to serve a wider array of healthcare providers and critically ill patients by enhancing their existing portfolio with these advanced ventilator technologies.
The acquired product lines consist of a variety of ventilator devices designed for both neonatal and adult care, making them suitable for various medical environments including hospitals and transport services. This acquisition not only includes the devices but also encompasses associated consumables, service parts, and accessories, thereby providing comprehensive support to healthcare providers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The medical device industry, particularly in the realm of respiratory care, is experiencing significant growth due to an increasing prevalence of respiratory diseases and an aging population. As healthcare priorities shift toward
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Patient Square Capital → Premier, Inc.
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
ZOLL Medical
invested in
Vyaire Medical’s ventilator business
in 2024
in a Buyout deal